MUMBAI, India, July 31 -- Intellectual Property India has published a patent application (202541004382 A) filed by Biophore India Pharmaceuticals Pvt. Ltd on January 20, 2025, for Oral Liquid Compositions Of Pitolisant Or A Pharmaceutically Acceptable Thereof.
Inventors include Manik Reddy Pullagurla; Srinivas Arutla; and Jagadeesh Babu Rangisetty.
The application for the patent was published on July 24, 2026, under issue no. 30/2026.
Abstract: The present invention provides pharmaceutical compositions comprising compounds which are selective antagonist or inverse agonist of the histamine H3 receptor, their manufacture and their use for the treatment of excessive daytime sleepiness (EDS) or cataplexy in patients with narcolepsy. Further, the present invention provides an oral liquid composition of Pitolisant or its pharmaceutically acceptable salt thereof and a process of making the same.
Disclaimer: Curated by HT Syndication.
